作者: Stefano Fiorucci , Roberto Pellicciari , Mark Pruzanski
DOI:
关键词:
摘要: The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the farnesoid X receptor (FXR) is expressed. This involves step of administering high potency, activating ligand FXR effective amount patient who not suffering from cholestatic condition. also provides pharmaceutical compositions containing and kits dispensing compositions.